Accredited CME programs are no longer the only legally sanctioned forum for education about off-label uses of drugs and medical devices. In a July 30 decision, U.S. District Judge Royce C. Lamberth ruled that FDA regulations that prohibit drug and device companies from disseminating information about off-label uses are a violation of the manufacturers' commercial speech rights. The Washington Legal Foundation, a nonprofit public interest law and policy center that objects to government
Register to view the full article
Register for MeetingsNet.com and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.
0 comments
Hide comments